Sara El Hoss
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Erratum to: "Optimizing CRISPR methodology for precise gene editing in the erythroid cell line BEL-A with high efficiency generation of a sickle cell anemia model".
Journal: Haematologica
Published: January 01, 2026
ZEB1 drives terminal erythroid maturation by controlling the GATA2-KLF1 regulatory switch.
Journal: Nucleic acids research
Published: December 17, 2025
Erythropoiesis in health and disease: Distinguishing defective and ineffective erythropoiesis.
Journal: HemaSphere
Published: September 05, 2025
Optimizing CRISPR methodology for precise gene editing in the erythroid cell line BEL-A with high efficiency generation of a sickle cell anemia model.
Journal: Haematologica
Published: December 18, 2024
From old to new: Repurposed drugs in the battle towards curing sickle cell disease.
Journal: British journal of haematology
Published: October 31, 2024
Reduced GATA1 levels are associated with ineffective erythropoiesis in sickle cell anemia.
Journal: Haematologica
Published: June 04, 2024
Comparative histological analysis of spleens in pediatric patients with hemolytic anemias: Insights into the pathophysiological mechanisms of spleen destruction in sickle cell anemia.
Journal: American journal of hematology
Published: February 09, 2024
Revolutionising healing: Gene Editing's breakthrough against sickle cell disease.
Journal: Blood reviews
Published: October 25, 2023
Unveiling P. vivax invasion pathways in Duffy-negative individuals.
Journal: Cell host & microbe
Published: June 06, 2023
Males with sickle cell disease have higher risks of cerebrovascular disease, increased inflammation, and a reduced response to hydroxyurea.
Journal: American journal of hematology
Published: May 23, 2023
Last Updated: 09/26/2026